Loading...
Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
Fusion-positive rhabdomyosarcoma (FP-RMS) is a highly aggressive childhood malignancy which is mainly treated by conventional chemotherapy, surgery and radiation therapy. Since radiotherapy is associated with a high burden of late side effects in pediatric patients, addition of radiosensitizers woul...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8239363/ https://ncbi.nlm.nih.gov/pubmed/34211841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.664462 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|